Crosstalk between genomic abnormality and transcription activity for acquisition of stem cell property of cancer
Project/Area Number |
17K19585
|
Research Category |
Grant-in-Aid for Challenging Research (Exploratory)
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor biology and related fields
|
Research Institution | Kanazawa University |
Principal Investigator |
HIRAO Atsushi 金沢大学, がん進展制御研究所, 教授 (90343350)
|
Research Collaborator |
Kobayashi Masahiko
|
Project Period (FY) |
2017-06-30 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Fiscal Year 2018: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2017: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
|
Keywords | 脳腫瘍 / 幹細胞 / がん幹細胞 / がん |
Outline of Final Research Achievements |
In this study, we aimed to understand relationship between genomic abnormality and transcription activity for acquisition of stem cell property of brain tumor. We found that primary human astrocytes were immortalized by introducing gene mutations of 4 major tumor suppressors or oncogenes, however, they did not form remarkable tumor mass in vivo, unlike patient-derived glioma samples. In addition, introduction of 4 transcription factors which reportedly contribute to acquisition of stem cell property of differentiated glioma cells were not able to transform immortalized astrocytes into malignant status, indicating that additional mutations are required. In the paralleled experiments, we successfully generated a patient-derived glioma cell clone, in which GFP was inserted at the locus of a stem cell marker gene. Since this GFP system is useful for visualization of stemness of tumor, we expect that it contributes to discovery of factors essential for acquisition of cancer stemness.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究により,がんの幹細胞特性の獲得には多くの因子の異常が複雑に関連していることが明らかとなった。また,本研究で得られた解析ツールを用いることにより,今後,未分化性獲得に必須のシグナルや治療標的を特定することにつながると期待された。本研究を通して得られた成果は,がんの診断,予防,治療の発展に寄与すると考えられ,将来,健康福祉の観点から社会に貢献することが期待される。
|
Report
(3 results)
Research Products
(11 results)
-
-
-
[Journal Article] Autophagy inhibition synergizes with calcium mobilization to achieve efficient therapy of malignant gliomas.2018
Author(s)
Vu HT, Kobayashi M, Hegazy AM, Tadokoro Y, Ueno M, Kasahara A, Takase Y, Nomura N, Peng H, Ito C, Ino Y, Todo T, Nakada M, Hirao A
-
Journal Title
Cancer Science
Volume: 109
Issue: 8
Pages: 2497-2508
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Distinct roles of Rheb and Raptor in activating mTOR complex 1 for the self-renewal of hematopoietic stem cells2018
Author(s)
Hui Peng, Atsuo Kasada, Masaya Ueno, Takayuki Hoshii, Yuko Tadokoro, Naho Nomura, Chiaki Ito, Yusuke Takase, Ha Thi Vu, Masahiko Kobayashi, Bo Xiao, Paul F. Worley, Atsushi Hirao
-
Journal Title
Biochemical and Biophysical Research Communications
Volume: 495
Issue: 1
Pages: 1129-1135
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug2017
Author(s)
Dong Y, Furuta T, Sabit H, Kitabayashi T, Jiapaer S, Kobayashi M, Ino Y, Todo T, Teng L, Hirao A, Zhao SG, Nakada M
-
Journal Title
Oncotarget
Volume: 8
Issue: 67
Pages: 111728-111741
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-